155 related articles for article (PubMed ID: 15679413)
41. Evaluation of the updated confocal laser endomicroscopy criteria for Barrett's esophagus among gastrointestinal pathologists.
Tofteland N; Singh M; Gaddam S; Wani SB; Gupta N; Rastogi A; Bansal A; Kanakadandi V; McGregor DH; Ulusarac O; Cherian R; Mathur SC; Sharma P
Dis Esophagus; 2014; 27(7):623-9. PubMed ID: 24006939
[TBL] [Abstract][Full Text] [Related]
42. Genetic markers and premalignancy.
Grandjouan S
Am J Gastroenterol; 1996 May; 91(5):844-6. PubMed ID: 8633569
[No Abstract] [Full Text] [Related]
43. Genomic alterations in malignant transformation of Barrett's esophagus.
Riegman PH; Vissers KJ; Alers JC; Geelen E; Hop WC; Tilanus HW; van Dekken H
Cancer Res; 2001 Apr; 61(7):3164-70. PubMed ID: 11306503
[TBL] [Abstract][Full Text] [Related]
44. Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett's Esophagus.
Vennalaganti P; Kanakadandi V; Goldblum JR; Mathur SC; Patil DT; Offerhaus GJ; Meijer SL; Vieth M; Odze RD; Shreyas S; Parasa S; Gupta N; Repici A; Bansal A; Mohammad T; Sharma P
Gastroenterology; 2017 Feb; 152(3):564-570.e4. PubMed ID: 27818167
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: proposal for a new classification system of gastrointestinal epithelial neoplasia.
Schlemper RJ; Kato Y; Stolte M
J Gastroenterol Hepatol; 2000 Oct; 15 Suppl():G49-57. PubMed ID: 11100994
[TBL] [Abstract][Full Text] [Related]
46. CpG island methylation in precursors of gastrointestinal malignancies.
Chan AO; Rashid A
Curr Mol Med; 2006 Jun; 6(4):401-8. PubMed ID: 16900663
[TBL] [Abstract][Full Text] [Related]
47. Advanced precancerous lesions within the GI tract: the molecular background.
Fassan M; Baffa R; Kiss A
Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):159-69. PubMed ID: 23809238
[TBL] [Abstract][Full Text] [Related]
48. Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract.
Hansel DE; Wilentz RE; Yeo CJ; Schulick RD; Montgomery E; Maitra A
Am J Surg Pathol; 2004 Mar; 28(3):347-56. PubMed ID: 15104297
[TBL] [Abstract][Full Text] [Related]
49. Everything you always wanted to know about GIST (but were afraid to ask) An update on GIST pathology.
Ricci R; Saragoni L
Pathologica; 2016 Sep; 108(3):90-103. PubMed ID: 28195260
[TBL] [Abstract][Full Text] [Related]
50. [The dysplasia-carcinoma sequence in the colorectum].
Hermanek P
Zentralbl Chir; 1992; 117(9):476-82. PubMed ID: 1441785
[TBL] [Abstract][Full Text] [Related]
51. [Pathogenetic aspects in precursor lesions of gastrointestinal tumors].
Rau T
Pathologe; 2016 Nov; 37(Suppl 2):186-190. PubMed ID: 27638535
[TBL] [Abstract][Full Text] [Related]
52. Gastric foveolar dysplasia: a survey of reporting habits and diagnostic criteria.
Serra S; Ali R; Bateman AC; Dasgupta K; Deshpande V; Driman DK; Gibbons D; Grin A; Hafezi-Bakhtiari S; Sheahan K; Srivastava A; Szentgyorgyi E; Vajpeyi R; Walsh S; Wang LM; Chetty R
Pathology; 2017 Jun; 49(4):391-396. PubMed ID: 28438394
[TBL] [Abstract][Full Text] [Related]
53. Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists.
Kerkhof M; van Dekken H; Steyerberg EW; Meijer GA; Mulder AH; de Bruïne A; Driessen A; ten Kate FJ; Kusters JG; Kuipers EJ; Siersema PD;
Histopathology; 2007 Jun; 50(7):920-7. PubMed ID: 17543082
[TBL] [Abstract][Full Text] [Related]
54. Barrett's dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry.
Kaye PV; Haider SA; Ilyas M; James PD; Soomro I; Faisal W; Catton J; Parsons SL; Ragunath K
Histopathology; 2009 May; 54(6):699-712. PubMed ID: 19438745
[TBL] [Abstract][Full Text] [Related]
55. The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence.
Polkowski W; van Lanschot JJ; Ten Kate FJ; Baak JP; Tytgat GN; Obertop H; Voorn WJ; Offerhaus GJ
Surg Oncol; 1995 Jun; 4(3):163-71. PubMed ID: 7582189
[TBL] [Abstract][Full Text] [Related]
56. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
Kim KM; Lee EJ; Kim YH; Chang DK; Odze RD
Am J Surg Pathol; 2010 May; 34(5):667-75. PubMed ID: 20305537
[TBL] [Abstract][Full Text] [Related]
57. Molecular markers in dysplasia of the larynx: expression of cyclin-dependent kinase inhibitors p21, p27 and p53 tumour suppressor gene in predicting cancer risk.
Jeannon JP; Soames JV; Aston V; Stafford FW; Wilson JA
Clin Otolaryngol Allied Sci; 2004 Dec; 29(6):698-704. PubMed ID: 15533163
[TBL] [Abstract][Full Text] [Related]
58. [Critical study of digestive tract dysplasia].
Jouret A; Haot J
Acta Gastroenterol Belg; 1992; 55(4):380-8. PubMed ID: 1462750
[TBL] [Abstract][Full Text] [Related]
59. Barrett's esophagus: diagnostic challenges and recent developments.
Maru DM
Ann Diagn Pathol; 2009 Jun; 13(3):212-21. PubMed ID: 19433303
[TBL] [Abstract][Full Text] [Related]
60. The biology of inherited disorders of the gastrointestinal tract part I: gastrointestinal disorders.
Martín MG
J Pediatr Gastroenterol Nutr; 1998 Mar; 26(3):321-35. PubMed ID: 9523870
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
